Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$61,790.00
Jul 1, 2025
For-profit organization
Scale up and validation of new oyster growing system
1032120
The project involves the experimental validation of a newly developed variable buoyancy oyster farming system designed by King Aquaculture Inc. Originally tested in larger formats, the system has been optimized into a smaller, more manageable version. The goal is to enhance the productivity and sustainability of oyster aquaculture by comparing the performance of this new system with traditional floating cage systems.
In 2024, the project focused on testing this smaller version of the variable buoyancy system at an experimental farm set up on a 5-hectare lease (MS-1236) in Bedec, NB. Key activities included monitoring oyster growth, mortality, and yield and assessing environmental impacts such as sediment accumulation. These experiments AI
$30,000.00
Jul 1, 2025
For-profit organization
Youth - Electrical Engineer
1032121
To provide a Youth with employment experience in the field of Electrical Engineering.
$30,000.00
Jul 1, 2025
For-profit organization
Youth - Cell Biology
1032166
Youth - Cell Biology
$73,000.00
Jul 1, 2025
For-profit organization
Experimentation to optimize business processes in website change detection, monitoring and alerting
1032167
This project will test hypotheses and experiment with new mechanisms to design and optimize a repeatable and scalable business process, which may result in new business methods for website change detection, monitoring and alerting
$93,596.00
Jul 1, 2025
For-profit organization
Improvements to Device
1032178
2S Water is advancing its AquaValid sensor, which provides real-time detection of dissolved metals in water to improve industrial efficiency and sustainability. Over the next year, R&D will focus on improving accuracy, increasing uptime, and ensuring reliable operation in high-altitude environments common in lithium mining.
$30,000.00
Jul 1, 2025
For-profit organization
Development of Novel EGFR Inhibitors as Cancer Therapeutics
1032219
Firm would like to design and develop novel EGFR (epidermal growth factor receptor) inhibitor cancer therapeutic that improve selectivity to allow irreversible inhibition to overcome resistance mutations. EGFR plays a central role in cell proliferation and survival. Aberrant EGFR signaling is a driver mutation in many tumors, making it an ideal and validated target for cancer therapy. Despite many pharmaceutical companies actively advancing EGFR inhibitors, drug resistance and severe side effects remain unsolved challenges that need to be addressed.
$50,400.00
Jul 1, 2025
For-profit organization
Development of Novel Quinazoline-Based EGFR Inhibitors as Cancer Therapeutics
1032220
Firm would like to design and develop novel EGFR (epidermal growth factor receptor) inhibitor cancer therapeutic that improve selectivity to allow irreversible inhibition to overcome resistance mutations. EGFR plays a central role in cell proliferation and survival. Aberrant EGFR signaling is a driver mutation in many tumors, making it an ideal and validated target for cancer therapy. Despite many pharmaceutical companies actively advancing EGFR inhibitors, drug resistance and severe side effects remain unsolved challenges that need to be addressed.
$30,000.00
Jul 1, 2025
For-profit organization
Dynamic Risk Index
1032245
This project leverages AI and automation to calculate and monitor trucking safety scores by analyzing CVSA inspection data alongside real-time insights from FleetShield, supporting improved compliance, proactive risk management, and enhanced public road safety.
$73,355.00
Jul 1, 2025
For-profit organization
Technical Solution Strategies for Increased Market Share and Scalability
1032275
Modernization and upgrade of software platform to increase technical functionality and scalability for greater commercialization potential.
$42,480.00
Jul 1, 2025
For-profit organization
Research Data Management (RDM) Integration of Research Data Using FHIR Standard to Import/Export Healthcare Data
1032279
Development of a research-agnostic FHIR-standard API integration from a generalist research data management repository to support the integration of clinical trial data from/to medical devices and EMR platforms.